New Diagnostic System Quickly and Accurately Measures Antibodies Against the COVID-19 Virus
A research team at the RIKEN Center for Emergent Matter Science (CEMS) in Japan has developed a diagnostic system that can rapidly and sensitively measure…
Browsing tag
A research team at the RIKEN Center for Emergent Matter Science (CEMS) in Japan has developed a diagnostic system that can rapidly and sensitively measure…
In the fight against viruses, antibodies have the potential to either block infection or enable infection and make the disease worse, leading to concern about…
An antibody therapy that appears to neutralize all known SARS-CoV-2 strains, and other coronaviruses, was developed with a little help from structural biologist Jay Nix….
Targets key part of virus’ spike protein that changes little across variants. The virus that causes COVID-19 today is not the same as the one…
New research has shown that many of the symptoms in fibromyalgia syndrome are caused by antibodies that increase the activity of pain-sensing nerves throughout the…
Researchers identify mechanisms of resistance to drug for triple-negative breast cancer. Massachusetts General Hospital (MGH) researchers have identified for the first time how a highly…
Scientists have repurposed the genetic modification technology CRISPR to identify antibodies in patient blood samples in a move that could inspire a new class of…
One dose of a new monoclonal antibody discovered and developed at the National Institutes of Health safely prevented malaria for up to nine months in…
Near-Atomic Look at Three Ways To Thwart SARS-CoV-2 Variants SARS-CoV-2 nanobodies—microscopic molecules developed at the University of Pittsburgh School of Medicine that neutralize the virus…
The SEROCOV study also provides evidence that pre-existing antibodies to common cold coronaviruses may be protective. The levels of IgG antibodies against SARS-CoV-2 Spike protein remain…
Göttingen researchers have developed mini-antibodies that efficiently block the coronavirus SARS-CoV-2 and its dangerous new variants. These so-called nanobodies bind and neutralize the virus up…
Antibodies capable of neutralizing multiple SARS-CoV-2 strains can inform strategies for broadly protective COVID-19 booster vaccines. As the SARS-CoV-2 virus that causes COVID-19 continues to…
Testing of an entire Italian town shows antibody levels remain high nine months after SARS-CoV-2 infection, whether symptomatic or asymptomatic. Researchers from the University of…
Scientists perform the first detailed analysis of different antibodies produced by COVID patients to various parts of SARS-CoV-2. Blood tests to detect antibodies against SARS-CoV-2,…
Understanding how antibodies and antibody-secreting cells can fight against lung infection will provide new directions for improving vaccines to prevent severe respiratory infection and for…
The structural revelation could have implications as a therapeutic target in all SARS-CoV-2 variants. A tiny protein of SARS-CoV-2, the coronavirus that gives rise to…
Dominant G-form Spike protein ‘puts its head up’ more frequently to latch on to receptors, but that makes it more vulnerable to neutralization. Large-scale supercomputer…
Our Immune Systems Blanket the SARS-CoV-2 Spike Protein With Antibodies The most complete picture yet is coming into focus of how antibodies produced in people…